The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer

International Journal of Oncology

Volumn 41, Issue 2, 2012, Pages 476-482

  Tsukada, Tomoya ^a   Fushida, Sachio ^a   Harada, Shinichi ^a   Yagi, Yasumichi ^a   Kinoshita, Jun ^a   Oyama, Katsunobu ^a   Tajima, Hidehiro ^a   Fujita, Hideto ^a   Ninomiya, Itasu ^a   Fujimura, Takashi ^a   Ohta, Tetsuo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cell cell interaction; Epithelial mesenchymal transition; Fibrosis; Gastric cancer; Human peritoneal mesothelial cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CELL ACTIVATION; CELL CONTACT; CELL INVASION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; HUMAN; HUMAN CELL; HUMAN PERITONEAL MESOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; MESOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; STOMACH CANCER; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; COCULTURE TECHNIQUES; EPITHELIAL CELLS; EPITHELIUM; FEMALE; FIBROSIS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OMENTUM; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR BURDEN; TUMOR MICROENVIRONMENT;

EID: 84863576521     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1490     Document Type: Article

References (32)

1. Fushida S, Kinoshita J, Yagi Y, et al: Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: A feasibility and pharmacokinetic study. Oncol Rep 19: 1305-1310, 2008.
2. Yonemura Y, Elnemr A, Endou Y, et al: Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol 2: 85-97, 2010.
3. Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
4. Tlsty TD: Stromal cells can contribute oncogenic signals. Semin Cancer Biol 11: 97-104, 2001.
5. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R: Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67: 10123-10128, 2007. (Pubitemid 350070783)
6. Pietras K, Ostman A: Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316: 1324-1331, 2010.
7. De Wever O, Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol 200: 429-447, 2003. (Pubitemid 36818244)
8. Yashiro M, Chung YS, Sowa M: Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res 85: 883-886, 1994. (Pubitemid 24294744)
9. Semba S, Kodama Y, Ohnuma K, et al: Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells. Br J Cancer 101: 1365-1373, 2009.
10. Nakazawa K, Yashiro M, Hirakawa K: Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 63: 8848-8852, 2003. (Pubitemid 38064064)
11. Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 264: 169-184, 2001. (Pubitemid 32989090)
12. Durning P, Schor SL, Sellwood RA: Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro. Lancet 2: 890-892, 1984. (Pubitemid 15201130)
13. Schor SL, Schor AM, Grey AM, Rushton G: Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. J Cell Sci 90: 391-399, 1988.
14. Grünert S, Jechlinger M, Beug H: Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4: 657-665, 2003. (Pubitemid 36934968)
15. Brenmoehl J, Miller SN, Hofmann C, et al: Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration. World J Gastroenterol 15: 1431-1442, 2009.
16. Andersson-Sjöland A, Erjefält JS, Bjermer L, Eriksson L, Westergren-Thorsson G: Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis. Respir Res 10: 103, 2009.
17. Tahara E: Abnormal growth factor/cytokine network in gastric cancer. Cancer Microenviron 1: 85-91, 2008.
18. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M, Tahara E: Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas. Int J Cancer 44: 394-398, 1989. (Pubitemid 19229293)
19. Wells RG. Fibrogenesis. V: TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 279: G845-850, 2000.
20. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358, 2000. (Pubitemid 30408720)
21. Zavadil J, Böttinger EP: TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774, 2005.
22. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
23. Zhang XY, Pettengell R, Nasiri N, Kalia V, Dalgleish AG, Barton DP: Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources. J Soc Gynecol Investig 6: 333-340, 1999. (Pubitemid 30009767)
24. Jayne DG, Perry SL, Morrison E, Farmery SM, Guillou PJ: Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. Br J Cancer 82: 1233-1238, 2000. (Pubitemid 30128884)
25. Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S, Kikkawa F: Possible involvement of SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of migratory potential in human peritoneal mesothelial cells. Cell Tissue Res 330: 221-229, 2007. (Pubitemid 47512585)
26. Aroeira LS, Aguilera A, Sánchez-Tomero JA, et al: Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18: 2004-2013, 2007. (Pubitemid 47041064)
27. Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M: Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 74: 1406-1412, 1996. (Pubitemid 26370731)
28. Yung S, Li FK, Chan TM: Peritoneal mesothelial cell culture and biology. Perit Dial Int 26: 162-173, 2006. (Pubitemid 44336164)
29. Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M: Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis 14: 43-54, 1996. (Pubitemid 26008959)
30. Yashiro M, Chung YS, Inoue T, et al: Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination. Int J Cancer 67: 289-293, 1996.
31. Yang S, Pham LK, Liao CP, Frenkel B, Reddi AH, Roy-Burman P: A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Res 68: 198-205, 2008. (Pubitemid 351380121)
32. Yasumoto K, Koizumi K, Kawashima A, et al: Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66: 2181-2187, 2006.